✨ Your Portfolio is fetched and updated from zerodha.
Large Pharmaceuticals

Mankind Pharma Ltd.

MANKIND

Market Cap
₹1,05,003 Cr.
P/E
51.44

Mankind Pharma Ltd.

  • Mankind Pharma
  • Dr. Reddy's Lab
  • Torrent Pharma
FAQs on Mankind Pharma Ltd. Shareprice

Mankind Pharma has given lower returns compared to its competitors.
Mankind Pharma has grown at ~6.37% over the last 1yrs while peers have grown at a median rate of 14.05%

Mankind Pharma is not expensive.
Latest PE of Mankind Pharma is 51.44, while 3 year average PE is 51.84.
Also latest EV/EBITDA of Mankind Pharma is 35.32 while 3yr average is 36.65.

View FAQ's On Business
Growth Table
  • Mankind Pharma Ltd.
  • Dr. Reddy's Lab
  • Torrent Pharma
Balance Sheet
  • Mankind Pharma Ltd.
  • Dr. Reddy's Lab
  • Torrent Pharma
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Mankind Pharma Ltd.
  • Dr. Reddy's Lab
  • Torrent Pharma
Cash Flow
  • Mankind Pharma Ltd.
  • Dr. Reddy's Lab
  • Torrent Pharma
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Mankind Pharma Ltd.
  • Dr. Reddy's Lab
  • Torrent Pharma
Quarterly Results
  • Mankind Pharma Ltd.
  • Dr. Reddy's Lab
  • Torrent Pharma
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Mankind Pharma Ltd. Financials

Balance sheet of Mankind Pharma is strong.
It shouldn't have solvency or liquidity issues.

Yes, The debt of Mankind Pharma is increasing.
Latest debt of Mankind Pharma is -₹720.65 Crs as of Sep-24.
This is greater than Mar-24 when it was -₹2,199.17 Crs.

Yes, profit is increasing.
The profit of Mankind Pharma is ₹2,051 Crs for TTM, ₹1,913 Crs for Mar 2024 and ₹1,282 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Mankind Pharma latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech